399 related articles for article (PubMed ID: 33426092)
1. Is there a Role of Intravenous Immunoglobulin in Immunologic Recurrent Pregnancy Loss?
Yang X; Meng T
J Immunol Res; 2020; 2020():6672865. PubMed ID: 33426092
[TBL] [Abstract][Full Text] [Related]
2. Effect of Intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL).
Ahmadi M; Abdolmohammadi-Vahid S; Ghaebi M; Aghebati-Maleki L; Afkham A; Danaii S; Abdollahi-Fard S; Heidari L; Jadidi-Niaragh F; Younesi V; Nouri M; Yousefi M
Biomed Pharmacother; 2017 Aug; 92():1095-1102. PubMed ID: 28622710
[TBL] [Abstract][Full Text] [Related]
3. Intravenous Immunoglobulin G Improves Pregnancy Outcome in Women with Recurrent Pregnancy Losses with Cellular Immune Abnormalities.
Lee SK; Kim JY; Han AR; Hur SE; Kim CJ; Kim TH; Cho BR; Han JW; Han SG; Na BJ; Kwak-Kim J
Am J Reprod Immunol; 2016 Jan; 75(1):59-68. PubMed ID: 26510488
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss.
Banjar S; Kadour E; Khoudja R; Ton-Leclerc S; Beauchamp C; Beltempo M; Dahan MH; Gold P; Jacques Kadoch I; Jamal W; Laskin C; Mahutte N; Reinblatt SL; Sylvestre C; Buckett W; Genest G
Am J Reprod Immunol; 2023 Aug; 90(2):e13737. PubMed ID: 37491929
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of immunologic abortion with low-dose intravenous immunoglobulin.
Stricker RB; Steinleitner A; Bookoff CN; Weckstein LN; Winger EE
Fertil Steril; 2000 Mar; 73(3):536-40. PubMed ID: 10689009
[TBL] [Abstract][Full Text] [Related]
6. [Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL)].
Sapir T; Carp H; Shoenfeld Y
Harefuah; 2005 Jun; 144(6):415-20, 454, 453. PubMed ID: 15999561
[TBL] [Abstract][Full Text] [Related]
7. Effect of IgG therapy on lymphocyte subpopulations in the peripheral blood of Kuwaiti women experiencing recurrent pregnancy loss.
Mahmoud F; Diejomaoh M; Omu A; Abul H; Haines D
Gynecol Obstet Invest; 2004; 58(2):77-83. PubMed ID: 15114031
[TBL] [Abstract][Full Text] [Related]
8. Treatment with intravenous immunoglobulin in patients with recurrent pregnancy loss: An update.
Christiansen OB; Kolte AM; Krog MC; Nielsen HS; Egerup P
J Reprod Immunol; 2019 Jun; 133():37-42. PubMed ID: 31238263
[TBL] [Abstract][Full Text] [Related]
9. NK cell frequency and cytotoxicity in correlation to pregnancy outcome and response to IVIG therapy among women with recurrent pregnancy loss.
Ahmadi M; Ghaebi M; Abdolmohammadi-Vahid S; Abbaspour-Aghdam S; Hamdi K; Abdollahi-Fard S; Danaii S; Mosapour P; Koushaeian L; Dolati S; Rikhtegar R; Oskouei FD; Aghebati-Maleki L; Nouri M; Yousefi M
J Cell Physiol; 2019 Jun; 234(6):9428-9437. PubMed ID: 30317625
[TBL] [Abstract][Full Text] [Related]
10. Update on treatment of immunologic abortion with low-dose intravenous immunoglobulin.
Stricker RB; Winger EE
Am J Reprod Immunol; 2005 Dec; 54(6):390-6. PubMed ID: 16305665
[TBL] [Abstract][Full Text] [Related]
11. Determination of clinical cellular immune markers in women with recurrent pregnancy loss.
Lee SK; Na BJ; Kim JY; Hur SE; Lee M; Gilman-Sachs A; Kwak-Kim J
Am J Reprod Immunol; 2013 Nov; 70(5):398-411. PubMed ID: 23656517
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin G modulates peripheral blood Th17 and Foxp3(+) regulatory T cells in pregnant women with recurrent pregnancy loss.
Kim DJ; Lee SK; Kim JY; Na BJ; Hur SE; Lee M; Kwak-Kim J
Am J Reprod Immunol; 2014 May; 71(5):441-50. PubMed ID: 24645850
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Empirical Treatment With Intravenous Immunoglobulin G Combined With Low-Dose Aspirin in Women With Unexplained Recurrent Pregnancy Loss.
Kim JH; Kim SH; Yang N; Ko Y; Lee SR; Chae HD
J Korean Med Sci; 2022 Jun; 37(25):e200. PubMed ID: 35762143
[TBL] [Abstract][Full Text] [Related]
14. A novel update on vitamin D in recurrent pregnancy loss (Review).
Zhao H; Wei X; Yang X
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760145
[TBL] [Abstract][Full Text] [Related]
15. Preimplantation factor inhibits circulating natural killer cell cytotoxicity and reduces CD69 expression: implications for recurrent pregnancy loss therapy.
Roussev RG; Dons'koi BV; Stamatkin C; Ramu S; Chernyshov VP; Coulam CB; Barnea ER
Reprod Biomed Online; 2013 Jan; 26(1):79-87. PubMed ID: 23186554
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D deficiency may be a risk factor for recurrent pregnancy losses by increasing cellular immunity and autoimmunity.
Ota K; Dambaeva S; Han AR; Beaman K; Gilman-Sachs A; Kwak-Kim J
Hum Reprod; 2014 Feb; 29(2):208-19. PubMed ID: 24277747
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
Sapir T; Blank M; Shoenfeld Y
Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
[TBL] [Abstract][Full Text] [Related]
18. High doses of intravenous immunoglobulin stimulate regulatory T cell and suppress natural killer cell in women with recurrent pregnancy loss.
Yamada H; Deguchi M; Saito S; Takeshita T; Mitsui M; Saito T; Nagamatsu T; Takakuwa K; Nakatsuka M; Yoneda S; Egashira K; Tachibana M; Matsubara K; Honda R; Fukui A; Tanaka K; Sengoku K; Endo T; Yata H
J Reprod Immunol; 2023 Aug; 158():103977. PubMed ID: 37354783
[TBL] [Abstract][Full Text] [Related]
19. Intravenous Immunoglobulin Suppresses Abortion Relates to an Increase in the CD44bright NK Subset in Recurrent Pregnancy Loss Model Mice.
Tanaka J; Kitashoji A; Fukunaga Y; Kashihara J; Nakano A; Kamizono A
Biol Reprod; 2016 Aug; 95(2):37. PubMed ID: 27335067
[TBL] [Abstract][Full Text] [Related]
20. A systemic review of intravenous immunoglobulin G treatment in women with recurrent implantation failures and recurrent pregnancy losses.
Saab W; Seshadri S; Huang C; Alsubki L; Sung N; Kwak-Kim J
Am J Reprod Immunol; 2021 Apr; 85(4):e13395. PubMed ID: 33511656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
